Johnson & Johnson is now solely a medical device and pharmaceutical company, and its stock provides investors with exposure to those markets. Kenvue handles the consumer health business. Shareholders of Johnson & Johnson were given the option to swap their shares for Kenvue stock. The offer expired in August 2023.